Carcinogenicity study of β-cyclodextrin in F344 rats

Food and Chemical Toxicology

Volumn 35, Issue 3-4, 1997, Pages 331-336

  Toyoda, K ^a   Shoda, T ^a   Uneyama, C ^a   Takada, K ^a   Takahashi, M ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Carcinogenicity study; F344 rats; Cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GROWTH; HISTOLOGY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA;

EID: 0030988861     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(97)00128-2     Document Type: Article

References (13)

1. Bellringer M. E., Smith T. G., Read R., Gopinath C. and Olivier Ph. (1995) β-Cyclodextrin: 52-week toxicity studies in the rat and dog. Food and Chemical Toxicology 33, 367-376.
2. Frank D. W., Gray J. E. and Weaver R. N. (1976) Cyclodextrin nephrosis in the rat. American Journal of Pathology 83, 367-382.
3. Goodman D. G., Ward J. M., Squire R. A., Chu K. C. and Linhart M. S. (1979) Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicology and Applied Pharmacology 48, 237-248.
4. Maekawa A., Kurokawa Y., Takahashi M., Kokubo T., Ogiu T., Onodera H., Tanigawa H., Ohno Y., Furukawa F. and Hayashi Y. (1983) Spontaneous tumors in F344/DuCrj rats. Gann 74, 365-372.
5. Maekawa A. (1990) Characteristics of F344 rats in a standpoint of naturally occurring neoplastic and non-neoplastic lesions (in Japanese). Experimental Animals 39, 507-517.
6. Pitha J., Szente L. and Szejtli J. (1985) Molecular encapsulation of drugs by cyclodextrins and congeners. In Controlled Drug Delivery. Edited by S. D. Bruck. pp. 126-148. CRC Press, Boca Raton, FL.
7. Solleveld H. A., Haseman J. K. and McConnell E. E. (1984) Natural history of body weight gain, survival, and neoplasia in the F344 rat. Journal of the National Cancer Institute 72, 929-940.
8. Szejtli J. and Sebestyén G. (1979) Resorption, metabolism and toxicity studies on the peroral application of beta-cyclodextrin. Starch/Stärke 31, 385-389.
9. Szejtli J. (1987) The metabolism, toxicity and biological effects of cyclodextrins. In Cyclodextrins and Their Industrial Uses. Edited by D. Duchêne. p. 175-210. Editions de Santé, Paris.
10. Szejtli J. (1990) The metabolism, toxicity and biological effects of cyclodextrins. In Drug Investigation Supplement. New Strategies in the Management of Pain. Vol. 2. Suppl. 4. Edited by A. Berti and V. Pipitone. pp. 11-21. Adis International, Hong Kong.
11. Toyoda K., Hayashi S., Uneyama C., Kawanishi T., Takada K. and Takahashi M. (1995) Hepatic lesions in F344 rats treated orally with β-cyclodextrin for 13 weeks (in Japanese). Bulletin of the National Institute of Health Sciences. Tokyo 113, 36-43.
12. Waner T., Borelli G., Cadel S., Privman I. and Nyska A. (1995) Investigation of potential oncogenic effects of β-cyclodextrin in the rat and mouse. Archives of Toxicology 69, 631-639.
13. WHO (1993) Technical Report no. 837. p. 24. WHO, Geneva.